Don't Ignore The Insider Selling In CONMED
New Analyst Forecast: $CNMD Given $61.0 Price Target
Positive Earnings Growth Hasn't Been Enough to Get CONMED (NYSE:CNMD) Shareholders a Favorable Return Over the Last Three Years
Needham Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $61
Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $80
Stifel Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $55
Conmed Corporation's Earnings Call: Mixed Results Amid Growth and Challenges
Conmed Price Target Cut to $58.00/Share From $70.00 by JP Morgan
CONMED Up Over 14%, on Pace for Largest Percent Increase Since November 2020 -- Data Talk
CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday
$CNMD Stock Is up 16% Today. Here's What We See in Our Data.
Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $57
ConMed | 10-Q: Q1 2025 Earnings Report
Conmed Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Guidance.
Conmed Is Maintained at Buy by Needham
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Breaking Down Conmed: 6 Analysts Share Their Views
Conmed Analyst Ratings
Piper Sandler Reaffirms Their Buy Rating on Conmed (CNMD)
Conmed's Strong Q1 Performance and Raised Guidance Justify Buy Rating Despite Tariff Challenges